|
PAFAH1B2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.4432899320127E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.47240014519912E-11 |
| Normal-vs-Stage2 |
1.20749999998893E-08 |
| Normal-vs-Stage3 |
4.12336831345783E-13 |
| Normal-vs-Stage4 |
1.62581059726108E-12 |
| Stage1-vs-Stage2 |
3.261200E-01 |
| Stage1-vs-Stage3 |
4.695700E-03 |
| Stage1-vs-Stage4 |
9.64239999999839E-05 |
| Stage2-vs-Stage3 |
3.093800E-01 |
| Stage2-vs-Stage4 |
4.495700E-02 |
| Stage3-vs-Stage4 |
2.577000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63580260448271E-12 |
| Normal-vs-AfricanAmerican |
1.99318339610954E-12 |
| Normal-vs-Asian |
9.889700E-02 |
| Caucasian-vs-AfricanAmerican |
1.649590E-02 |
| Caucasian-vs-Asian |
2.403000E-01 |
| AfricanAmerican-vs-Asian |
4.426000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33226762955019E-15 |
| Normal-vs-Female |
1.98600025314022E-11 |
| Male-vs-Female |
1.245640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.59699999999763E-05 |
| Normal-vs-Age(41-60Yrs) |
4.51882975482931E-12 |
| Normal-vs-Age(61-80Yrs) |
1.63213886850144E-12 |
| Normal-vs-Age(81-100Yrs) |
8.97849999903499E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.504800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.546800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.255400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.802000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.375600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.908600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.179600E-02 |
| Normal-vs-Grade 2 |
2.42319497800736E-11 |
| Normal-vs-Grade 3 |
1.63846713974181E-12 |
| Normal-vs-Grade 4 |
1.63091762317435E-12 |
| Grade 1-vs-Grade 2 |
4.460400E-01 |
| Grade 1-vs-Grade 3 |
1.353820E-01 |
| Grade 1-vs-Grade 4 |
2.144000E-02 |
| Grade 2-vs-Grade 3 |
2.178400E-02 |
| Grade 2-vs-Grade 4 |
3.394400E-04 |
| Grade 3-vs-Grade 4 |
7.193900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.76680003960428E-09 |
| Normal-vs-ccB subtype |
1.32650002093726E-10 |
| ccA subtype-vs-ccB subtype |
7.689900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.62634358705327E-12 |
| Normal-vs-N1 |
2.347700E-02 |
| N0-vs-N1 |
9.468600E-01 |
|
|
